HPBCD is a unique component in Janssen’s COVID-19 vaccine candidate
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
A forum for researchers, students and applicants in the field of cyclodextrin technology
Amongst Janssen’s novel single-dose Covid-19 vaccine candidate of adenovirus platform excipients one might notice a peculiar compound: Hydroxypropyl Betadex (HPBCD).
A retrospective study based on data collected from Memorial Sloan-Kettering Cancer Center, New York shows high efficacy and low toxicity
A very few patent applications may trace back prior art disclosure to the Neolithic Age (from 10000 – 4500 BC)
1986, the year of the first issue of Cyclodextrin News was abundant in notable events and new threats to be
A French research consortium (Institut National Polytechnique de Toulouse, Ecole D’ingenieurs de Purpan, Universite Paul Sabatier Toulouse, Centre National de
The cover paper of PNAS (1) presents a concept for promoting the neuronal regenerative potential by engineering the expression of
The 37th Japanese National Cyclodextrin Symposium (planned to be held between Sept. 3-4, 2020 at Osaka University) will be postponed
ADAMA MAKHTESHIM LTD. (Israel) filed a PCT patent application (WO2020084572) that was recently published. The invention relates to preparation and use
Use of cyclodextrins in contact lens cleaning solutions is dating back to almost thirty years. A patent application was filed
Coronavirus SARS-CoV caused an outbreak of severe acute respiratory syndrome (SARS) emerged in Guangdong Province, People’s Republic of China in